Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Most patients tolerate treatment very well, but some may experience nausea, constipation, bloating, or fatigue during the first few weeks
A study in the New England Journal of Medicine highlighted that participants using a GLP-1 experienced weight loss that included both fat and lean mass
New numbness, wrist pain, or worsening sleep apnea symptoms should be discussed with a clinician
Coverage for weight loss is a different story: only 13 states cover obesity-indicated GLP-1s as of January 2026, and that number has been shrinking as states face budget pressure
RAA: rapid-acting insulin analogue
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 26.79
US$ 20.38
US$ 26.75
US$ 22.06
